These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8108339)

  • 21. Proceedings: Immunosuppressive consequences of the treatment of ulcerative colitis with azathioprine.
    Skinner JM; Campbell AC; Waller C; Wood J; MacLennan IC
    Gut; 1974 Oct; 15(10):828-9. PubMed ID: 4611752
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis.
    Tareyeva IE; Shilov EM; Gordovskaya NB
    Clin Nephrol; 1980 Nov; 14(5):233-7. PubMed ID: 6971722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA; Gergert VIa; Iakovleva OB
    Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between peripheral T cell reactivity to insulin, clinical remissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus.
    Mayer A; Rharbaoui F; Thivolet C; Orgiazzi J; Madec AM
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2419-24. PubMed ID: 10404814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunotherapeutic management of juvenile diabetes mellitus].
    Moncada E
    Rev Esp Fisiol; 1989; 45 Suppl():301-8. PubMed ID: 2701766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of immunosuppressive and anti-inflammatory drugs on lymphocyte population and MIF in glomerulonephritis.
    Janas-Boratyńska M; Szewczyk Z
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):833-45. PubMed ID: 398689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular immune alterations associated with human insulin therapy.
    Eichner HL; Lauritano AA; Woertz LL; Selam JL; Gupta S; Charles MA
    Diabetes Res; 1988 Jul; 8(3):111-5. PubMed ID: 3067952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of human insulin on clinical remission and the immunologic aspect newly-diagnosed type 1 (insulin-dependent) diabetes mellitus].
    Giordano C; Sinagra D; Botta RM; Donatelli M; Galluzzo A
    Minerva Endocrinol; 1984; 9(2):121-3. PubMed ID: 6390125
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of manganese on immunologic response of the body].
    Talakin IuN; Savchenko MV; Ivanova LA; Bakaeva NV; Baĭdalin MP
    Gig Sanit; 1992 Feb; (2):38-40. PubMed ID: 1427159
    [No Abstract]   [Full Text] [Related]  

  • 30. Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine.
    Harrison LC; Colman PG; Dean B; Baxter R; Martin FI
    Diabetes; 1985 Dec; 34(12):1306-8. PubMed ID: 3905463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of azathioprine on in vitro antibody response. Differential effect on B cells involved in thymus-dependent and independent responses.
    Galanaud P; Crevon MC; Dormont J
    Clin Exp Immunol; 1975 Oct; 22(1):139-52. PubMed ID: 1082392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Disorders of cellular immunity in newly detected diabetes mellitus type 1].
    Skuratowicz-Kubica A; Mysliwska J; Bakowska A; Lass P; Horoszek-Maziarz S
    Pol Tyg Lek; 1988 Mar; 43(10):325-8. PubMed ID: 3261421
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lymphocyte immunophenotype in children with diabetes mellitus type I during long-term insulin therapy].
    Zak KP; Malynovs'ka TM; Hruzov MA
    Lik Sprava; 2001; (3):44-7. PubMed ID: 11560025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis.
    Oger JJ; Antel JP; Kuo HH; Arnason BG
    Ann Neurol; 1982 Feb; 11(2):177-81. PubMed ID: 6462102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cellular immunity in patients with diabetes mellitus complicated by diabetic retinopathies].
    Danilova AI; Dekhtiareva OS
    Probl Endokrinol (Mosk); 1984; 30(5):29-34. PubMed ID: 6334294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitus.
    Pozzilli P; Zuccarini O; Sensi M; Spencer KM; Bottazzo G
    Biomed Biochim Acta; 1984; 43(5):621-5. PubMed ID: 6236800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual B cell activity and insulin requirements in insulin-dependent diabetic patients treated from the beginning with high doses of nicotinamide. A two-year follow-up.
    Taboga C; Tonutti L; Noacco C
    Recenti Prog Med; 1994 Nov; 85(11):513-6. PubMed ID: 7855383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [State of the T and B immunity systems in diabetes mellitus in children].
    Martynova MI; Smirnov VV; Semenkov VF; Akimova ON
    Pediatriia; 1980 Jun; (6):36-8. PubMed ID: 6967590
    [No Abstract]   [Full Text] [Related]  

  • 40. [Change of the complement level in patients with insulin-dependent diabetes mellitus in the course of intensified insulin therapy].
    Kozlov LV; Ageev VP; Sizoĭ MN; Beskova NS; Dedov II; Shamkhalova MSh; Abugova IA
    Probl Endokrinol (Mosk); 1992; 38(2):12-4. PubMed ID: 1513764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.